The Patent Finder
US

RNA Interference in Dermal and Fibrotic Indications

US 9,963,702 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed May 8, 2026 on the fee record · High confidence

Second maintenance fee unpaid; grace period ended.

Filed Apr 14, 2016 as application 15/099,481 · Granted May 8, 2018
Base term, 20 years from filing
Today
Lapsed May 8, 2026
2011 2031
Clock starts
Mar 24, 2011
No longer in force
May 8, 2026
Granted
May 8, 2018
Term would have run to
Mar 24, 2031
base term after the term ends fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

Its term would have run to Mar 24, 2031: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 24, 2011, when application PCT/US2011/029867, the earliest non-provisional in its chain, was filed (this one was filed Apr 14, 2016)Mar 24, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidlapsed May 8, 2026High confidence
Computed term endThe steps above, in orderMay 8, 2026High confidence

This family

Application PCT/US2011/029867PCT application
no patent term
no patent term
US 9,340,786In force
Mar 2031
Mar 2031
US 9,963,702this patent
May 2026
May 2026
US 10,913,948In force
Mar 2031
Mar 2031
Application 17/150,934Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 14, 2016
Reel 39337, frame 648
Khvorova, Anastasia; Salomon, William; Kamens, Joanne; Samarsky, Dmitry; Woolf, Tod M.; Pavco, Pamela A.; Libertine, Lyn; Cardia, James; Bulock, Karen G.Rxi Pharmaceuticals CorporationAssignment of Assignor's Interest
Dec 7, 2018
Reel 48380, frame 9
Rxi Pharmaceuticals CorporationPhio Pharmaceuticals Corp.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited